Fulcrum Therapeutics (FULC) Interest & Investment Income (2020 - 2026)
Fulcrum Therapeutics' (FULC) quarterly Interest & Investment Income came in at -$687000.0 in Q1 2026, down 1045.0% year-on-year from $72698.4 in Q1 2025, and down 925.37% on a QoQ basis from -$67000.0 in Q4 2025.
Fulcrum Therapeutics (FULC) Interest & Investment Income (2020 - 2026) Analysis & Trends
Fulcrum Therapeutics (FULC) has 7 years of Interest & Investment Income data on file, last reported at -$687000.0 in Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 1045.0% year-over-year to -$687000.0 in Q1 2026; TTM through Mar 2026 was -$583000.0, a 215.67% decrease from a year earlier, with the FY2025 full-year figure at $44000.0, down 83.46% from the prior year.
- Interest & Investment Income for Q1 2026 stood at -$687000.0, down from -$67000.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for FULC reached as high as $745000.0 in Q3 2024 and fell as low as -$693000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged -$111615.4 across 5 years, with a median of -$60000.0 in 2025.
- On a YoY basis, Interest & Investment Income climbed as much as 540.0% in 2022 and fell as far as 34550.0% in 2022.
- Year by year, Interest & Investment Income stood at $22000.0 in 2022, then sank by 2595.45% to -$549000.0 in 2023, then jumped by 54.64% to -$249000.0 in 2024, then soared by 73.09% to -$67000.0 in 2025, then slumped by 925.37% to -$687000.0 in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were -$687000.0 in Q1 2026, -$67000.0 in Q4 2025, and $159000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Fulcrum Therapeutics | 285.43 Mn | 285.43 Mn | - | -687,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -687,000.00 |
| Dec 31, 2025 | -67,000.00 |
| Sep 30, 2025 | 159,000.00 |
| Jun 30, 2025 | 12,000.00 |
| Mar 31, 2025 | -60,000.00 |
| Dec 31, 2024 | -249,000.00 |
| Sep 30, 2024 | 745,000.00 |
| Jun 30, 2024 | 68,000.00 |
| Mar 31, 2024 | -298,000.00 |
| Jun 30, 2023 | -549,000.00 |
| Mar 31, 2023 | 146,000.00 |
| Jun 30, 2022 | 22,000.00 |
| Mar 31, 2022 | -693,000.00 |
| Dec 31, 2021 | -310,000.00 |
| Sep 30, 2021 | -78,000.00 |
| Jun 30, 2021 | -5,000.00 |
| Mar 31, 2021 | -2,000.00 |
| Dec 31, 2020 | -33,000.00 |
| Sep 30, 2020 | -50,000.00 |
| Jun 30, 2020 | 134,000.00 |